Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Stephen Stefani"'
Autor:
Luciana Castro Garcia Landeiro, Tamie de Camargo Martins, Ruth Bartelli Grigolon, Isabel Monteiro, Joana Bisol Balardin, Eduardo Padilha, Gilberto Amorim, Stephen Stefani
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionBreast cancer (BC) is one of the leading causes of cancer and is the first cause of death from malignant tumors among women worldwide. New cancer therapies receive regulatory approval yearly and to avoid health disparities in society, the
Externí odkaz:
https://doaj.org/article/4658c43d9b634fe9a44fd94670a6fb0d
Autor:
Tamie de Camargo Martins, Ruth B Grigolon, Isabel Monteiro, Joana Bisol Balardin, Eduardo Padilha, Gilberto Amorim, Stephen Stefani, Luciana Castro Garcia Landeiro
Publikováno v:
Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 8, Iss s. 2 (2023)
Introdução: O câncer de mama (CM) é um dos tipos de câncer mais prevalentes e é a primeira causa de morte por tumores malignos entre as mulheres em todo o mundo. Novas terapias recebem aprovação regulatória anualmente, e os sistemas de saúd
Externí odkaz:
https://doaj.org/article/afae0c71c5da4ca292abb111b35ed795
Autor:
Isabela Werneck da Cunha, Renata de Almeida Coudry, Mariana Petaccia de Macedo, Emilio Augusto Campos Pereira de Assis, Stephen Stefani, Fernando Augusto Soares
Publikováno v:
Surgical and Experimental Pathology, Vol 4, Iss 1, Pp 1-27 (2021)
Abstract Background Adoption of molecular pathology in Brazil is currently very limited. Of note, there are no programs for training new molecular pathologists in the country; thus, documents compiling nationally applicable information on molecular p
Externí odkaz:
https://doaj.org/article/dab21f75143d4a3f95b646777d0879bd
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The global burden of breast cancer (BC) is high, especially in advanced stages. CDK 4/6 inhibitors represent a paradigm shift in the treatment of advanced BC HR+/HER2−, given the clinically and statistically significant gain in overall
Externí odkaz:
https://doaj.org/article/547bbd57509a417a9e4efb56c8f1ce73
Autor:
Isabela Werneck da Cunha, Renata de Almeida Coudry, Mariana Petaccia de Macedo, Emilio Augusto Campos Pereira de Assis, Stephen Stefani, Fernando Augusto Soares
Publikováno v:
Surgical and Experimental Pathology, Vol 4, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/6ffc3db77fd745ea83c7b542d08af6c7
Publikováno v:
The Lancet Oncology. 24:581-582
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward
Autor:
Tania Pastrana, Pamela C Chavez, Stephen Stefani, Ji Seok Kim, Francisco Gutiérrez-Delgado, Eduardo Cazap, Bettina Müller, Julia Ismael, Nelson Teich, Cynthia Villarreal-Garza, Enrique Soto-Perez-de-Celis, Suyapa A Bejarano Cáceres, Lucía Delgado, Taiane F Rebelatto, Alejandro Mohar, Gustavo Werutsky, Carlos Barrios, Carlos José Castro E, Yolanda Vargas, Brittany L. Bychkovsky, Luiz A Santini, Yanin Chavarri-Guerra, Pedro Exman, Ana S. Ferrigno, Romualdo Barroso-Sousa, Pedro E.R. Liedke, Claudia Uribe
Publikováno v:
The Lancet Oncology. 22:e474-e487
The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015 highlighted potential interventions that could advance cancer care in the region by overcoming exis
Autor:
Renata de Almeida Coudry, Isabela Werneck da Cunha, Emilio Augusto Campos Pereira de Assis, Stephen Stefani, Fernando Augusto Soares, Mariana Petaccia de Macedo
Publikováno v:
Surgical and Experimental Pathology, Vol 4, Iss 1, Pp 1-27 (2021)
Background Adoption of molecular pathology in Brazil is currently very limited. Of note, there are no programs for training new molecular pathologists in the country; thus, documents compiling nationally applicable information on molecular pathology
Autor:
Teresa Lemmer, Peter Serafini, Ana Paula Bueno, Bernardo Pires, Grupo Oncoclínicas, São Paulo, Sp, Brasil, Ipsen Brasil, São Paulo, Sp, Brasil, André Mello, Stephen Stefani
Publikováno v:
Jornal Brasileiro de Economia da Saúde. 12:39-55
Autor:
Cristina Gutierrez Delgado, Virginia Abello, Martha Alvarado, Daniel Lew, Dario Londoño, Elizabeth McElwee, Mariana Rico Restrepo, Natalia Schutz, Stephen Stefani, Angelo Maiolino
Publikováno v:
RAS Oncology & Therapy. 3
Purpose: To address the barriers limiting access to combination therapies (CTs) in Latin America (LA), specifically for patients with multiple myeloma (MM), alongside a roadmap to address them. Methods: A panel of LA experts was provided with relevan